Novel Target Study to Cure Cardiovascular Disease regarding Proprotein Converse Subtilisin/Kexin Type 9

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">ZINC ID</td><td class="align_center">CDOCKER interaction energy (Kcal/mol)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">ZINC000004099069</td><td class="align_center">-87.8609</td></tr><tr><td class="align_left">ZINC000014952116</td><td class="align_center">-65.9632</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>CDOCKER interaction energy of compounds with PCSK9.</div>

BioMed Research International

tab4

Table 4

Table 4: Novel Target Study to Cure Cardiovascular Disease regarding Proprotein Converse Subtilisin/Kexin Type 9 